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In their review, Esteban-Vasallo et al. (2012) 
discussed the use of human placenta to eval-
uate bio markers of exposure to heavy metals. 
They correctly concluded that the use of pla-
cental tissue specimens to assess heavy metal 
exposure is actually under used. Surprisingly, 
they did not mention the well-documented 
relationship between mercury released from 
mercury-containing dental amalgam fillings 
and mercury disposition in placental tissues 
(Clarkson and Magos 2006; Gundacker 
and Hengstschläger 2012; Richardson et al. 
2011). 
Studies have suggested an association 
between mercury levels in placental tissues 
and the observed mercury dental amalgams 
in women (Ask et al. 2002; Palkovicova et al. 
2008; Richardson et al. 2011). Elevated pla-
cental mercury levels have been reported 
in dental workers who, throughout preg-
nancy, were exposed to mercury vapor (Hg0) 
released during preparation of mercury 
amalgam in dental offices (Guzzi and Pigatto 
2007; Wannag and Skjaeråsen 1975). As 
noted by Drasch et al. (1994), the mother-
to-fetus transfer of mercury Hg0 from amal-
gams has been reported in human autopsy 
samples, and elevated levels of total mercury 
have been observed in the brain, liver, and 
kidney of human fetuses; these levels have 
been linked to the number of maternal amal-
gam-restored surfaces. 
Trans placental exposure to heavy metals 
may affect child growth and cause neuro-
developmental delays. Thus, further efforts 
should be made to measure and quantify 
maternal exposure to heavy metals in placenta 
to estimate environmental prenatal exposure.
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We appreciate the interest of Pigatto et al. in 
our review (Esteban-Vasallo et al. 2012). We 
understand their concern regarding mercury 
amalgams; however, the purpose of our review 
was to summarize the available information 
on total mercury, cadmium, and lead levels 
in human placental tissue, obtained from 
studies that reported original quantitative 
data. Published evidence suggests a possible 
association between mercury released from 
mercury-containing dental amalgam fillings 
and levels of this metal in diverse fetal tissues 
(kidney, brain, and cord blood) (Drasch 
et al. 1994). In contrast, studies focusing on 
human placenta and amalgams are scarce 
and their results inconsistent. The only two 
studies included in our review that assessed a 
possible relationship between dental fillings 
and total mercury—a small study in Taiwan 
(46 women) (Hsu et al. 2007) and another 
in Jamaica (52 women) (Grant et al. 2010)—
found no association. Only Ask et al. (2002) 
reported higher mercury levels in mothers with 
a higher number of fillings, but they studied 
inorganic mercury and not total mercury. 
None of the studies mentioned by Pigatto 
et al. in their letter (Clarkson and Magos 
2006; Gundacker and Hengstschlager 2012; 
Richardson et al. 2011) includes original data, 
although we did identify an additional refer-
ence from those articles that might provide 
more data on this issue, a symposium abstract 
by Ursinyova et al. (2006). In this abstract, 
the authors described a significant correlation 
between the number of amalgams and placen-
tal mercury levels in 409 women; however, 
these findings have not yet been published 
in a full report that would allow us to better 
evaluate the results. In addition, Wannag and 
Skjaeråsen (1975) seemed to provide original 
information, but we were unable to find this 
paper for our review. In this context, we have 
to disagree with Pigatto et al.; in our opinion, 
the association between mercury exposure 
from dental amalgam fillings and levels of this 
metal in human placenta cannot yet be con-
sidered as well-established.
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In their article, Strak et al. (2012) connected 
real-world exposure to markers of acute lung 
function and inflammation. However, some 
points in the paper require further explana-
tion. Strak et al. used fractional exhaled nitric 
oxide (FENO) as a marker of lung inflamma-
tion. Exhaled NO is produced throughout 
the respiratory tract and shows significant 
variability in source strength across the respi-
ratory tract (Barnes et al. 2010; Kharitonov 
and Barnes 2001). Factors such as particle 
size, hygro scopicity, composition, and con-
centration; lung function parameters; and 
environ mental temperature and humidity 
(Varghese and Gangamma 2006, 2009), 
which vary across experimental locations and 
between participants, modify particle deposi-
tion sites in the lung. These changes in the 
deposition site may influence the amount 
of NO exhaled. In their paper, Strak et al. 
(2012) did not discuss how these parameters 
influenced their conclusions. Thus, how the 
linear regression model they used accounts 
for these influences needs to be explained. 
Inflammation in the lung resulting from 
air pollution exposure involves various cell 
types, such as epithelial cells in upper airways 
and macrophages and recruited neutrophils in 
the lower respiratory tract. A significant source 
of exhaled NO is epithelial cells in the upper 
airways, which are associated with eosinophilic 
inflammation (Barnes et al. 2010; Kharitonov 
and Barnes 2001). Many components of par-
ticulate matter (PM), such as endotoxin or 
bacteria, induce neutrophil inflammation in 
the lung, but the effects of these components 
may not be reflected in the concentration of 
exhaled NO. Thus, FENO measurements as a 
marker of inflammation could easily be mis-
interpreted by attributing a particular part of 
the total inflammatory response within the 
lung to air pollution. Strak et al. (2012) did 
not discuss such possibilities. 
In their article, Strak et al. (2012) did 
not provide sufficient details about the 
NIOX MINO monitor (Aerocrine 2010) 
they used to measure exhaled NO concen-
tration. I assume that NO measurement 
involves flow measurement and diffusion of 
NO to a sensor. Temperature and humidity 
of exhaled air or body temperature of the 
subjects likely interfere with these opera tions. 
Strak et al. did not describe any of these 
parameters or how they may interfere with 
NO measurement. Moreover, the absolute 
values of FENO observed during the experi-
ments are not readily available. However, 
in the “Discussion,” Strak et al. indicated 
that the observed variations between FENO 
measure ments that are associated with parti-
cle number concentration (PNC) were most 
likely within the range of 5–15%. The tech-
nical specification of the instrument used for 
NO measure ment has precision values of 
5 ppb or 10% for concentrations > 30 ppb 
(Aerocrine 2010). Strak et al. used the dif-
ference between two sets of readings (pre-
exposure and post exposure) as the input data 
for regression calculations. Thus, measure-
ment error associated with the calculations 
could be much higher than that for a single 
set of measurements. Therefore, many of the 
observed differences in NO values were likely 
to fall within the error range of the instru-
ment. Strak et al. should have discussed the 
propagation of error in the measurements or 
provided sufficient experimental data on the 
precision of the measurements. They should 
also have explained how the regression analy-
sis is not biased by such instrument errors. 
Strak et al. (2012) reported measure-
ment of PNC with a condensation particle 
counter (CPC model 3007; TSI 2007), but 
their Table S2 did not report the accuracy or 
limit of detection of this instrument. CPC 
measure ment depends on parameters such as 
ion concentration and particle composition, 
but because the measurements in the paper 
were from different environments, it is likely 
that these parameters varied significantly 
across the sites. Moreover, the CPC has a low 
sampling flow rate, and it is not clear whether 
this sampling rate is suitable for ambient 
measure ment (aspiration efficiency in case of 
fluctuations in ambient wind velocity). 
Overall, the article is an excellent attempt 
by Strak et al. (2012) to use non invasive 
methods to understand the acute response of 
the respiratory system in response to air pollu-
tion exposure. However, a careful explanation 
of theory behind the experiments, experimen-
tal design, and limitations of measure ment 
methods (if any) should have been discussed 
in the article. 
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We thank Gangamma for a number of excel-
lent observa tions and would like to respond 
to the issues raised.
Gangamma points out that the levels of 
fractional exhaled nitric oxide (FENO) may be 
influenced by the site of particle deposition in 
the lung and requests further explanation on 
how this could affect the analysis and conclu-
sion of our study (Strak et al. 2012). In an 
observational study such as ours, it is not 
possible to assess precise locations of particle 
deposition in the respiratory tract. Although 
variations in location of particle deposition 
likely introduced some noise in the FENO 
readings, we could not take this into account 
in the regression model.
Gangamma notes that many compo-
nents of particulate matter (PM) can induce 
neutro phil inflammation in the lung; thus, 
focusing only on FENO may not sufficiently 
reflect their effects. FENO is an indicator of 
airway inflammation that is used fairly often 
in observational and experimental studies. As 
we stated above, in a study such as ours (Strak 
et al. 2012), it would be very challenging to 
address many possible inflammation path-
ways. In addition, the focus of our study was 
more on the components and charac teristics 
of air pollution and associated health effects. 
We included other inflammatory markers 
(e.g., interleukin-6, neutrophils) measured 
both in blood and nasal lavage in our health 
measurements, but those were outside of the 
scope of our paper.
The next issue raised by Gangamma 
deals with the suggestion that many of the 
measured FENO values could be within error 
range of the measurement instrument; there-
fore, data on the precision of the measure-
ments should be provided and explanation 
should be given on how it could affect the 
regression analysis. Measurement error is an 
